0001127602-22-011550.txt : 20220405 0001127602-22-011550.hdr.sgml : 20220405 20220405161739 ACCESSION NUMBER: 0001127602-22-011550 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220317 FILED AS OF DATE: 20220405 DATE AS OF CHANGE: 20220405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Petrovic Shacey CENTRAL INDEX KEY: 0001631895 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 22807078 MAIL ADDRESS: STREET 1: 600 TECHNOLOGY PARK DRIVE STREET 2: SUITE 200 CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-03-17 0001145197 INSULET CORP PODD 0001631895 Petrovic Shacey C/O INSULET CORPORATION 100 NAGOG PARK ACTON MA 01720 1 1 President and CEO Common Stock 2022-03-17 5 G 0 E 19903 0 D 13607 D Common Stock 2022-03-17 5 G 0 E 19903 0 A 26304 I By SP Trust Common Stock 2022-04-04 4 M 0 15000 29.26 A 28607 D Common Stock 2022-04-04 4 S 0 15000 273.25 D 13607 D Common Stock 61259 I By NG Trust Employee Stock Option (Right to Buy) 29.26 2022-04-04 4 M 0 15000 0 D 2026-02-24 Common Stock 15000 7070 D On March 17, 2022, the reporting person transferred 19,903 shares of Insulet common stock to a family trust of which the reporting person is a trustee. The reporting person and members of her immediate family are beneficiaries of the trust. The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $270.79 to $279.59. Specifically: 4,146 shares were sold in the range of $270.79 to $271.77 per share, with a weighted average share price of $271.35; 1,928 shares were sold in the range of $271.79 to $272.73 per share, with a weighted average share price of $272.10; 3,111 shares were sold in the range of $272.80 to $273.77 per share, with a weighted average share price of $273.30; 3,618 shares were sold in the range of $273.78 to $274.77 per share, with a weighted average share price of $274.21; 1,413 shares were sold in the range of $274.78 to $275.35 per share, with a weighted average share price of $275.08; 200 shares were sold in the range of $276.09 to $276.37 per share, with a weighted average share price of $276.23; 142 shares were sold in the range of $277.64 to $278.39 per share, with a weighted average share price of $278.20 and 442 shares were sold in the range of $278.66 to $279.59 per share, with a weighted average share price of $279.28. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. /s/ John W. Kapples, attorney-in-fact 2022-04-05